FDA grants first clearance to AI program for diagnosing idiopathic pulmonary fibrosis
/
DateJan 16 2024
The artificial intelligence developer Imvaria has claimed a de novo clearance from the FDA for a digital diagnostic that analyzes chest CT scans for the... Read More →